<div id="readability-page-1"><div><p><span>IMMUNOMIC THERAPEUTICS :</span></p><ul><li>IMMUNOMIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR A UNITE®-BASED SELF-AMPLIFYING RNA VACCINE FOR TRIPLE-NEGATIVE BREAST CANCER, TO BE STUDIED ALONE AND IN COMBINATION WITH KEYTRUDA®</li></ul></div></div>

<p>IMMUNOMIC THERAPEUTICS :IMMUNOMIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR A UNITE®-BASED SELF-AMPLIFYING RNA VACCINE FOR TRIPLE-NEGATIVE BREAST CANCER, TO BE STUDIED ALONE AND IN COMBINATION WITH KEYTRUDA®</p>

Reuters

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

VG Health

Health Care Select Sector SPDR

SPDR S&P Biotech

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

Merck

iShares US Pharma

First Trust NYSE Arca Biotech Index Fd

Invesco Nasdaq Biotechnology ETF

iShares Global Healthcare

ALPS Medical Breakthrough

Ark Genomic Revolution ETF

Immunomic Therapeutics Announces FDA Clearance For ITI-5000